137 related articles for article (PubMed ID: 6384252)
41. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
[TBL] [Abstract][Full Text] [Related]
42. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
Pantazi H; Papapetrou PD
J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
[TBL] [Abstract][Full Text] [Related]
43. Obesity and postmenopausal bone loss: the influence of obesity on vertebral density and bone turnover in postmenopausal women.
Ribot C; Tremollieres F; Pouilles JM; Bonneu M; Germain F; Louvet JP
Bone; 1987; 8(6):327-31. PubMed ID: 2966634
[TBL] [Abstract][Full Text] [Related]
44. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study.
Langlois JA; Rosen CJ; Visser M; Hannan MT; Harris T; Wilson PW; Kiel DP
J Clin Endocrinol Metab; 1998 Dec; 83(12):4257-62. PubMed ID: 9851760
[TBL] [Abstract][Full Text] [Related]
45. The relation between calcium absorption, serum dehydroepiandrosterone, and vertebral mineral density in postmenopausal women.
Nordin BE; Robertson A; Seamark RF; Bridges A; Philcox JC; Need AG; Horowitz M; Morris HA; Deam S
J Clin Endocrinol Metab; 1985 Apr; 60(4):651-7. PubMed ID: 3156144
[TBL] [Abstract][Full Text] [Related]
46. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study.
Gravholt CH; Lauridsen AL; Brixen K; Mosekilde L; Heickendorff L; Christiansen JS
J Clin Endocrinol Metab; 2002 Jun; 87(6):2798-808. PubMed ID: 12050253
[TBL] [Abstract][Full Text] [Related]
47. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
[TBL] [Abstract][Full Text] [Related]
48. Age-related bone loss in women evaluated by the single and dual photon technique.
Nilas L; Gotfredsen A; Hadberg A; Christiansen C
Bone Miner; 1988 Apr; 4(1):95-103. PubMed ID: 3191275
[TBL] [Abstract][Full Text] [Related]
49. Skeletal mass in postmenopausal women.
Aloia JF; Cohn SH; Ross P; Vaswani A; Abesamis C; Ellis K; Zanzi I
Am J Physiol; 1978 Jul; 235(1):E82-7. PubMed ID: 677313
[TBL] [Abstract][Full Text] [Related]
50. Serum minerals (Ca, P, Co, Mn, Ni, Cd) and growth hormone (IGF-1 and IGF-2) levels in postmenopausal Saudi women with osteoporosis.
Yakout SM; Alharbi F; Abdi S; Al-Daghri NM; Al-Amro A; Khattak MNK
Medicine (Baltimore); 2020 Jul; 99(27):e20840. PubMed ID: 32629669
[TBL] [Abstract][Full Text] [Related]
51. The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.
Riis BJ; Rødbro P; Christiansen C
Calcif Tissue Int; 1986 Jun; 38(6):318-22. PubMed ID: 3089552
[TBL] [Abstract][Full Text] [Related]
52. Insulin-like growth factors I and II in healthy women with and without established osteoporosis.
Ravn P; Overgaard K; Spencer EM; Christiansen C
Eur J Endocrinol; 1995 Mar; 132(3):313-9. PubMed ID: 7889180
[TBL] [Abstract][Full Text] [Related]
53. Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause.
Nilas L; Christiansen C
Eur J Clin Invest; 1988 Oct; 18(5):529-34. PubMed ID: 3147906
[TBL] [Abstract][Full Text] [Related]
54. Bone mass and its relationship to age and the menopause.
Nilas L; Christiansen C
J Clin Endocrinol Metab; 1987 Oct; 65(4):697-702. PubMed ID: 3654915
[TBL] [Abstract][Full Text] [Related]
55. Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I: potential implications for age-related (type II) osteoporotic fracture occurrence.
Boonen S; Aerssens J; Dequeker J; Nicholson P; Cheng X; Lowet G; Verbeke G; Bouillon R
Calcif Tissue Int; 1997 Sep; 61(3):173-8. PubMed ID: 9262505
[TBL] [Abstract][Full Text] [Related]
56. Bone mineralization in women following successful treatment of Hodgkin's disease.
Redman JR; Bajorunas DR; Wong G; McDermott K; Gnecco C; Schneider R; Lacher MJ; Lane JM
Am J Med; 1988 Jul; 85(1):65-72. PubMed ID: 3389382
[TBL] [Abstract][Full Text] [Related]
57. Trabecular bone density and menstrual function in women runners.
Cook SD; Harding AF; Thomas KA; Morgan EL; Schnurpfeil KM; Haddad RJ
Am J Sports Med; 1987; 15(5):503-7. PubMed ID: 3674275
[TBL] [Abstract][Full Text] [Related]
58. Changes in bone mineral content of the axial skeleton in relation to aging and the menopause. Results from a longitudinal population study of women in Gothenburg, Sweden.
Lindquist O; Bengtsson C; Hansson T; Jonsson R
Scand J Clin Lab Invest; 1983 Jun; 43(4):333-8. PubMed ID: 6635539
[TBL] [Abstract][Full Text] [Related]
59. Postmenopausal bone loss at multiple skeletal sites: relationship to estrogen use.
Wasnich R; Yano K; Vogel J
J Chronic Dis; 1983; 36(11):781-90. PubMed ID: 6643645
[TBL] [Abstract][Full Text] [Related]
60. The presence of normal levels of serum immunoreactive insulin-like growth factor 2 (IGF-2) in patients with Down's syndrome.
Annerén G; Enberg G; Sara VR
Ups J Med Sci; 1984; 89(3):274-8. PubMed ID: 6240148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
